-

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Credit Suisse Group AG (CS) on Behalf of Investors

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Credit Suisse Group AG (“Credit Suisse” or the “Company”) (NYSE: CS) investors concerning the Company’s possible violations of federal securities laws.

On March 1, 2021, Credit Suisse froze $10 billion in funds that were invested in financial products from Greensill Capital (“Greensill”) and held by its supply-chain investment funds.

On March 8, 2021, Greensill filed for insolvency protection, and more than 1,000 investors in the Greensill funds marketed were unable to exit their positions.

On March 10, 2021, media reports revealed that Greensill investors had retained counsel and intended to sue Credit Suisse for their losses because Credit Suisse continued to market the biggest of the funds as a fully insured, low-risk product despite a decision by insurers during the summer of 2020 not to renew coverage.

On this news, the Company’s American Depositary Receipts (“ADRs”) fell $1.85, or 12.5%, to close at $12.85 per ADR on March 12, 2021, thereby injuring investors.

On Friday, March 26, 2021, several banks began liquidating billions of dollars’ worth of shares that Archegos Capital Management (“Archegos”) had swap positions on at fire sale prices after Archegos had failed to meet a margin call. By the time Credit Suisse tried to liquidate its own holdings of stocks underlying Archegos’ swap contracts over the following weekend, prices had collapsed and Credit Suisse amassed billions of dollars in losses.

On March 29, 2021, Credit Suisse conceded that “the loss resulting from this exit . . . could be highly significant and material to our first quarter results.” The Financial Times then pegged Credit Suisse’s estimated losses at between $3 billion and $5 billion, more than a year’s worth of the Company’s net profit.

On this news, the market price of Credit Suisse ADRs fell another nearly 20%, from a close of $13.21 per ADR on March 25, 2021 to close at $10.60 per ADR on March 31, 2021.

If you purchased Credit Suisse ADRs, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to howardsmith@howardsmithlaw.com, or visit our website at www.howardsmithlaw.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
888-638-4847
howardsmith@howardsmithlaw.com
www.howardsmithlaw.com

Law Offices of Howard G. Smith

NYSE:CS

Release Versions
$Cashtags

Contacts

Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
888-638-4847
howardsmith@howardsmithlaw.com
www.howardsmithlaw.com

More News From Law Offices of Howard G. Smith

Insulet Corporation (PODD) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Insulet Corporation (“Insulet” or the “Company”) (NASDAQ: PODD) investors concerning the Company’s possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN INSULET CORPORATION (PODD), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. Contact the Law Offices of Howard G. Smith to discuss your legal rights by e...

Deadline Approaching: Soleno Therapeutics, Inc. (SLNO) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith reminds investors of the upcoming May 5, 2026 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Soleno Therapeutics, Inc. (“Soleno” or the “Company”) (NASDAQ: SLNO) common stock between March 26, 2025 and November 4, 2026, inclusive (the “Class Period”). IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN SOLENO THERAPEUTICS, INC. (SLNO), CONTACT THE LAW OFFICES OF HOWARD G. SMITH TO PARTICIPA...

Law Offices of Howard G. Smith Encourages Nektar Therapeutics (NKTR) Shareholders To Inquire About Securities Fraud Class Action

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Nektar Therapeutics (“Nektar” or the “Company”) (NASDAQ: NKTR) securities between February 26, 2025 and December 15, 2025, inclusive (the “Class Period”). Nektar investors have until May 5, 2026 to file a lead plaintiff motion. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN NEKTAR THERAPEUTICS (NKTR), CONTACT THE LAW OFFICES OF HOWARD G. SMITH T...
Back to Newsroom